📰 Phenomix Sciences News
Phenomix Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Phenomix Sciences. Real-time updates on events, politics, business and more.
May 28, 2024
One of the big mysteries with popular GLP-1 medications for weight loss is why some people will lose 20% or more of their starting body weight on the drugs while
May 21, 2024
Research shows that a new test that assigns a genetic risk score to patients may be able to spot who is likely to be successful on injected weight-loss medications.
May 20, 2024
Researchers said patients with a specific genetic profile are most likely to benefit from the expensive medication
May 16, 2024
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
May 16, 2024
Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to t
April 11, 2024
Phenomix Sciences announced a new 3-in-1 obesity phenotype test that allows patients to identify the root causes of obesity.
April 4, 2024
/PRNewswire/ -- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces...
April 4, 2024
Phenomix Sciences launches a new MyPhenome test that identifies all three key obesity phenotypes in a single test.
January 24, 2024
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
November 14, 2023
Ever since injections promising to help people lose weight hit the shelves, interest around the world has been phenomenal. So high was demand, companies were finding it difficult to keep up with the demand.